Analyzing a Randomized Cancer Prevention Trial with a Missing Binary Outcome, an Auxiliary Variable, and All-or-None Compliance
含缺失二元结局、辅助变量与全有或全无依从性的随机癌症预防试验分析
The Prostate Cancer Prevention Trial is a randomized chemoprevention trial designed to compare the effect of daily finasteride versus placebo on prostate cancer determined by biopsy. Investigators have scheduled a biopsy at the end of the trial in 7 years or following a positive prostate-specific antigen (PSA) on annual screening. The analysis will need to adjust for two likely complications. First, some subjects will not receive a biopsy, depending in part on whether or not…